Search

Your search keyword '"Palmer, Christina G.S."' showing total 117 results

Search Constraints

Start Over You searched for: Author "Palmer, Christina G.S." Remove constraint Author: "Palmer, Christina G.S."
117 results on '"Palmer, Christina G.S."'

Search Results

1. Cohort Expansion and Genotype-Phenotype Analysis of RAB11A-Associated Neurodevelopmental Disorder

2. Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly

3. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

4. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

5. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

6. Genomics Research with Undiagnosed Children: Ethical Challenges at the Boundaries of Research and Clinical Care

7. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

8. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

9. De novo variants in MRTFB have gain-of-function activity in Drosophila and are associated with a novel neurodevelopmental phenotype with dysmorphic features

10. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

11. Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis

12. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

13. A syndromic neurodevelopmental disorder caused by rare variants in PPFIA3

14. Biallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy

15. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

16. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

17. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

18. Loss-of-function in RBBP5results in a syndromic neurodevelopmental disorder associated with microcephaly

19. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

20. One is the loneliest number: genotypic matchmaking using the electronic health record

21. Corrigendum to eP296-The yield of thorough record review in the Undiagnosed Diseases Network, Volume 132, Supplement 1, April 2021, Page S187, https://doi.org/10.1016/S1096-7192(21)00378-4

22. Correction to:An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (Genetics in Medicine, (2021), 23, 4, (740-750), 10.1038/s41436-020-01027-3)

24. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

25. Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder

26. HLA-B maternal-fetal genotype matching increases risk of schizophrenia

27. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

29. RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility

30. A genomewide scan for loci involved in attention-deficit/ hyperactivity disorder

31. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

32. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

33. Variants in PRKAR1Bcause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

36. Wisconsin cystic fibrosis chest radiograph scoring system

37. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

38. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

39. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

40. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

41. SLC35A2‐CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals

42. Bi-allelic Variants in TONSL Cause SPONASTRIME Dysplasia and a Spectrum of Skeletal Dysplasia Phenotypes

43. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

44. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

45. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

46. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.

47. The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed disease.

48. Effect of Genetic Diagnosis on Patients with Previously Undiagnosed Disease

49. IRF2BPL Is Associated with Neurological Phenotypes

50. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

Catalog

Books, media, physical & digital resources